Thrivent Financial for Lutherans
ROIV icon

Thrivent Financial for Lutherans’s Roivant Sciences ROIV Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-99,124
Closed -$1.12M – 2571
2025
Q2 		$1.12M Buy
99,124
+417
+0.4% +$4.52K ﹤0.01% 1719
2025
Q1 		$996K Sell
98,707
-2,349
-2% -$25.4K ﹤0.01% 1715
2024
Q4 		$1.2M Sell
101,056
-22,767
-18% -$269K ﹤0.01% 1799
2024
Q3 		$1.43M Sell
123,823
-62,228
-33% -$708K ﹤0.01% 1681
2024
Q2 		$1.97M Buy
186,051
+101,437
+120% +$1.11M ﹤0.01% 1393
2024
Q1 		$892K Buy
+84,614
New +$912K ﹤0.01% 1956

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Thrivent Financial for Lutherans's ROIV Position: Q3 2025 in Review

Thrivent Financial for Lutherans sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 99,124 shares — an estimated $1.12M sold.

Thrivent Financial for Lutherans first reported a position in ROIV in Q1 2024 and held it in 6 quarters. The position peaked at $1.97M in Q2 2024. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Thrivent Financial for Lutherans reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 99,124 Roivant Sciences shares in Q3 2025, an estimated $1.12M.
  • Thrivent Financial for Lutherans first reported a position in Roivant Sciences in Q1 2024 and held it in 6 quarters.
  • Thrivent Financial for Lutherans's Roivant Sciences position peaked at $1.97M in Q2 2024.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2025, filed 4 Nov 2025.